Lysogene Pushes Forward With Sanfilippo Syndrome Study, Establishes Footprint in U.S. Post author:Sam Post published:October 24, 2017 Post category:BioPharma Finding a treatment for Sanfilippo Syndrome is a personal matter for the Lysogene team. Source: BioSpace You Might Also Like Celyad Grants To Novartis AG A Non-Exclusive License For Its Allogeneic TCR-Deficient CAR-T Cells Patents May 1, 2017 Filings Reveal Founder & CEO Buy Adds $570K to Retractable Tech Stake August 30, 2017 Accuray Inc. Release: First Radixact System Research Results Presented At The August 3, 2017
Celyad Grants To Novartis AG A Non-Exclusive License For Its Allogeneic TCR-Deficient CAR-T Cells Patents May 1, 2017
